Cargando…

Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients

Patients with non-small cell lung cancer (NSCLC) have been shown to benefit from the introduction of anti-PD1 treatment. However, not all patients experience tumor regression and durable response. The identification of a string of markers that are direct or indirect indicators of the immune system f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zizzari, Ilaria Grazia, Filippo, Alessandra Di, Scirocchi, Fabio, Di Pietro, Francesca Romana, Rahimi, Hassan, Ugolini, Alessio, Scagnoli, Simone, Vernocchi, Pamela, Del Chierico, Federica, Putignani, Lorenza, Rughetti, Aurelia, Marchetti, Paolo, Nuti, Marianna, Botticelli, Andrea, Napoletano, Chiara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712566/ https://www.ncbi.nlm.nih.gov/pubmed/33158018 http://dx.doi.org/10.3390/jpm10040208

Ejemplares similares

The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot Study
por: Botticelli, Andrea, et al.
Publicado: (2021)

Immune effects of CDK4/6 inhibitors in patients with HR(+)/HER2(−) metastatic breast cancer: Relief from immunosuppression is associated with clinical response
por: Scirocchi, Fabio, et al.
Publicado: (2022)

Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis
por: Scirocchi, Fabio, et al.
Publicado: (2022)

Circulating CD137(+) T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients
por: Cirillo, Alessio, et al.
Publicado: (2023)

Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib
por: Scirocchi, Fabio, et al.
Publicado: (2021)

IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137(+)T-cells
por: Ugolini, Alessio, et al.
Publicado: (2020)

Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment
por: Botticelli, Andrea, et al.
Publicado: (2020)

Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma
por: Pace, Angelica, et al.
Publicado: (2022)

Circulating CD137(+) T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2022)

Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2020)

Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment
por: Botticelli, Andrea, et al.
Publicado: (2016)

Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs
por: Pace, Angelica, et al.
Publicado: (2023)

MGL Receptor and Immunity: When the Ligand Can Make the Difference
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2015)

The Macrophage Galactose-Type C-Type Lectin (MGL) Modulates Regulatory T Cell Functions
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2015)

Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity
por: Ceccarelli, Fulvia, et al.
Publicado: (2023)

Network Analysis of Gut Microbiome and Metabolome to Discover Microbiota-Linked Biomarkers in Patients Affected by Non-Small Cell Lung Cancer
por: Vernocchi, Pamela, et al.
Publicado: (2020)

Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets
por: Napoletano, Chiara, et al.
Publicado: (2019)

Immunohistochemical Characterization of Immune Infiltrate in Tumor Microenvironment of Glioblastoma
por: Rahimi Koshkaki, Hassan, et al.
Publicado: (2020)

A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab
por: Botticelli, Andrea, et al.
Publicado: (2019)

Immune Effects of Trastuzumab
por: Nuti, Marianna, et al.
Publicado: (2011)

Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health
por: Vernocchi, Pamela, et al.
Publicado: (2016)

Gut Microbiota Metabolism and Interaction with Food Components
por: Vernocchi, Pamela, et al.
Publicado: (2020)

Tumor associated MUC1 carried by microvesicles is cross-processed by dendritic cells generating CD8+ T cell response
por: Zizzari, Ilaria G, et al.
Publicado: (2013)

Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach
por: Botticelli, Andrea, et al.
Publicado: (2023)

Mediterranean Diet and Health: Food Effects on Gut Microbiota and Disease Control
por: Del Chierico, Federica, et al.
Publicado: (2014)

Monoclonal Antibodies in Gynecological Cancer: A Critical Point of View
por: Bellati, Filippo, et al.
Publicado: (2011)

A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors
por: Mezi, Silvia, et al.
Publicado: (2023)

Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
por: Botticelli, Andrea, et al.
Publicado: (2018)

Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial
por: ANTONILLI, MORENA, et al.
Publicado: (2016)

Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer
por: Napoletano, Chiara, et al.
Publicado: (2013)

Tumor-Derived Microvesicles Enhance Cross-Processing Ability of Clinical Grade Dendritic Cells
por: Dionisi, Marco, et al.
Publicado: (2018)

The sexist behaviour of immune checkpoint inhibitors in cancer therapy?
por: Botticelli, Andrea, et al.
Publicado: (2017)

Tumor-Derived Microvesicles Modulate Antigen Cross-Processing via Reactive Oxygen Species-Mediated Alkalinization of Phagosomal Compartment in Dendritic Cells
por: Battisti, Federico, et al.
Publicado: (2017)

HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2011)

A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics
por: Vernocchi, Pamela, et al.
Publicado: (2017)

Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1
por: Botticelli, Andrea, et al.
Publicado: (2020)

Investigating Patterns of Immune Interaction in Ovarian Cancer: Probing the O-glycoproteome by the Macrophage Galactose-Like C-Type Lectin (MGL)
por: Napoletano, Chiara, et al.
Publicado: (2020)

The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy
por: Botticelli, Andrea, et al.
Publicado: (2022)

Docosahexaenoic Acid Supplementation during Pregnancy: A Potential Tool to Prevent Membrane Rupture and Preterm Labor
por: Pietrantoni, Emanuela, et al.
Publicado: (2014)

Meta-Omic Platforms to Assist in the Understanding of NAFLD Gut Microbiota Alterations: Tools and Applications
por: Del Chierico, Federica, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_iqqh9106t2vj4fc13eqp3fh1ak